Search for stock quotes, financial statistics and more
Research Capital analyst Andre Uddin maintained his “Speculative Buy” rating and US$ 5.50 target... Read More
In a March 31 report, Research Capital analyst Andre Uddin maintained his “Speculative Buy” rati... Read More
In a Nov. 24 update, Research Capital analyst André Uddin maintained his “Speculative Buy” rati... Read More
Research Capital analyst Andre Uddin lowered his target price for NervGen Pharma (NervGen Pharma Sto... Read More
NervGen Pharma (NervGen Pharma Stock Quote, Chart, News, Analysts, Financials TSXV:NGEN) has appoint... Read More
Share
Tweet
pin
Share